Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Persistent behavioral impairment caused by embryonic methylphenidate exposure in zebrafish.

Publication ,  Journal Article
Levin, ED; Sledge, D; Roach, S; Petro, A; Donerly, S; Linney, E
Published in: Neurotoxicol Teratol
2011

As more adults take the stimulant medication methylphenidate to treat attention deficit hyperactivity disorder (ADHD) residual type, the risk arises with regard to exposure during early development if people taking the medication become pregnant. We studied the neurobehavioral effects of methylphenidate in zebrafish. Zebrafish offer cellular reporter systems, continuous visual access and molecular interventions such as morpholinos to help determine critical mechanisms underlying neurobehavioral teratogenicity. Previously, we had seen that persisting neurobehavioral impairment in zebrafish with developmental chlorpyrifos exposure was associated with disturbed dopamine systems. Because methylphenidate is an indirect dopamine agonist, it was thought that it might also cause persistent behavioral impairment after developmental exposure. Zebrafish embryos were exposed to the ADHD stimulant medication methylphenidate 0-5 days post fertilization (12.5-50mg/l). They were tested for long-term behavioral effects as adults. Methylphenidate exposure (50mg/l) caused significant increases in dopamine, norepinepherine and serotonin on day 6 but not day 30 after fertilization. In the novel tank diving test of predatory avoidance developmental methylphenidate (50mg/l) caused a significant reduction in the normal diving response. In the three-chamber spatial learning task early developmental methylphenidate (50mg/l) caused a significant impairment in choice accuracy. These data show that early developmental exposure of zebrafish to methylphenidate causes a long-term impairment in neurobehavioral plasticity. The identification of these functional deficits in zebrafish enables further studies with this model to determine how molecular and cellular mechanisms are disturbed to arrive at this compromised state.

Duke Scholars

Published In

Neurotoxicol Teratol

DOI

EISSN

1872-9738

Publication Date

2011

Volume

33

Issue

6

Start / End Page

668 / 673

Location

United States

Related Subject Headings

  • Zebrafish
  • Toxicology
  • Spatial Behavior
  • Reflex, Startle
  • Methylphenidate
  • Memory
  • Learning
  • Embryo, Nonmammalian
  • Dose-Response Relationship, Drug
  • Choice Behavior
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Levin, E. D., Sledge, D., Roach, S., Petro, A., Donerly, S., & Linney, E. (2011). Persistent behavioral impairment caused by embryonic methylphenidate exposure in zebrafish. Neurotoxicol Teratol, 33(6), 668–673. https://doi.org/10.1016/j.ntt.2011.06.004
Levin, Edward D., Damiyon Sledge, Stephanie Roach, Ann Petro, Susan Donerly, and Elwood Linney. “Persistent behavioral impairment caused by embryonic methylphenidate exposure in zebrafish.Neurotoxicol Teratol 33, no. 6 (2011): 668–73. https://doi.org/10.1016/j.ntt.2011.06.004.
Levin ED, Sledge D, Roach S, Petro A, Donerly S, Linney E. Persistent behavioral impairment caused by embryonic methylphenidate exposure in zebrafish. Neurotoxicol Teratol. 2011;33(6):668–73.
Levin, Edward D., et al. “Persistent behavioral impairment caused by embryonic methylphenidate exposure in zebrafish.Neurotoxicol Teratol, vol. 33, no. 6, 2011, pp. 668–73. Pubmed, doi:10.1016/j.ntt.2011.06.004.
Levin ED, Sledge D, Roach S, Petro A, Donerly S, Linney E. Persistent behavioral impairment caused by embryonic methylphenidate exposure in zebrafish. Neurotoxicol Teratol. 2011;33(6):668–673.
Journal cover image

Published In

Neurotoxicol Teratol

DOI

EISSN

1872-9738

Publication Date

2011

Volume

33

Issue

6

Start / End Page

668 / 673

Location

United States

Related Subject Headings

  • Zebrafish
  • Toxicology
  • Spatial Behavior
  • Reflex, Startle
  • Methylphenidate
  • Memory
  • Learning
  • Embryo, Nonmammalian
  • Dose-Response Relationship, Drug
  • Choice Behavior